東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Extreme hepatic surgery and other st...

Santibanes, Eduardo de.

FindBook

Google Book

Amazon

博客來

Extreme hepatic surgery and other strategies = increasing resectability in colorectal liver metastases /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Extreme hepatic surgery and other strategies/ edited by Eduardo de Santibanes ... [et al.].
其他題名:	increasing resectability in colorectal liver metastases /
其他作者:	Santibanes, Eduardo de.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	xix, 383 p. :ill. (some col.), digital ;24 cm.
內容註:	Part I Introduction. 1. Introduction -- 2. Liver surgical anatomy -- II. Global patient evaluation and oncological assessment -- 3. Resectability assessment with diagnostic imaging -- 4. Liver function evaluation before extreme liver surgery -- 5. Imaging-based preoperative planning -- 6. Choosing the best strategy. Multidisciplinary evaluation -- III -- Non-operative multimodal therapies -- 7. Conversion and neoadjuvant therapies -- 8. Portal embolization -- 9. Intraarterial chemotherapy -- 10. Radioembolization -- IV. Surgical strategies -- 11. Anesthetics management -- 12. Intraoperative evaluation of resectability -- 13. Vascular control in major hepatic resections -- 14. Two-stage liver surgery -- 15. Two-stage liver surgery with portal occlusion -- 16 ALPPS -- 17. Parenchymal-sparing liver resections -- 18. Combined vascular resections -- 19. Ex-vivo liver surgery -- 20. Liver transplant -- 21. The roll of laparoscopy in advanced liver disease -- V. Management of concomitant extrahepatic disease -- 22. Pulmonary metastases -- 23. Nodal involvement -- 24. Peritoneal disease -- 25. Adjacent organs invasion. Multivisceral resections -- VI. Postoperative complications and their management -- 26. Complications of hepatic resections -- VII. Palliative care -- 27. Palliative care in patients with extensive disease.
Contained By:	Springer eBooks
標題:	Liver - Surgery. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-13896-1
ISBN:	9783319138961

Extreme hepatic surgery and other strategies = increasing resectability in colorectal liver metastases /
Extreme hepatic surgery and other strategiesincreasing resectability in colorectal liver metastases /[electronic resource] :edited by Eduardo de Santibanes ... [et al.]. - Cham :Springer International Publishing :2017. - xix, 383 p. :ill. (some col.), digital ;24 cm.

Part I Introduction. 1. Introduction -- 2. Liver surgical anatomy -- II. Global patient evaluation and oncological assessment -- 3. Resectability assessment with diagnostic imaging -- 4. Liver function evaluation before extreme liver surgery -- 5. Imaging-based preoperative planning -- 6. Choosing the best strategy. Multidisciplinary evaluation -- III -- Non-operative multimodal therapies -- 7. Conversion and neoadjuvant therapies -- 8. Portal embolization -- 9. Intraarterial chemotherapy -- 10. Radioembolization -- IV. Surgical strategies -- 11. Anesthetics management -- 12. Intraoperative evaluation of resectability -- 13. Vascular control in major hepatic resections -- 14. Two-stage liver surgery -- 15. Two-stage liver surgery with portal occlusion -- 16 ALPPS -- 17. Parenchymal-sparing liver resections -- 18. Combined vascular resections -- 19. Ex-vivo liver surgery -- 20. Liver transplant -- 21. The roll of laparoscopy in advanced liver disease -- V. Management of concomitant extrahepatic disease -- 22. Pulmonary metastases -- 23. Nodal involvement -- 24. Peritoneal disease -- 25. Adjacent organs invasion. Multivisceral resections -- VI. Postoperative complications and their management -- 26. Complications of hepatic resections -- VII. Palliative care -- 27. Palliative care in patients with extensive disease.

This book describes the diagnoses; staging and management of patients with colorectal liver metastases initially considered unresectable and portrays the different strategies to increase resectability along with their tactics and tricks. Colorectal carcinoma is the third most commonly diagnosed cancer in the world and according to recent cancer statistics around 1.23 million patients are diagnosed each year. Of these patients, approximately 50% will develop liver metastases during the course of their disease and around 15-25% are found to have stage IV disease at diagnosis. Liver resection has been recognized as the treatment of choice for these patients, offering overall 5-year survival rates of up to 50-60% and the only hope for cure. However, at diagnosis only 10-20% of these patients are possibly amenable to surgical resection with curative intent. The possibility to achieve an R0 resection is many times limited by the amount and quality of the future liver remnant (FLR), being posthepatectomy liver failure (PHLF) the most feared and severe complication after major liver resections. With the years, diverse strategies have been developed with the intention to increase resectability by increasing the future liver remnant and/or reducing tumor size, e.g. ALPPS. Along with these techniques, associated surgeries are developed including multivisceral resections, which broadens even more the resectability for patients.

ISBN: 9783319138961

Standard No.: 10.1007/978-3-319-13896-1doiSubjects--Topical Terms:

1244617
Liver
--Surgery.

LC Class. No.: RD546

Dewey Class. No.: 617.5562

Extreme hepatic surgery and other strategies = increasing resectability in colorectal liver metastases /
LDR:03811nmm a2200325 a 4500 001 2105751
003 DE-He213
005 20180205154257.0
006 m d
007 cr nn 008maaau
008 180417s2017 gw s 0 eng d
020 $a 9783319138961 $q (electronic bk.)
020 $a 9783319138954 $q (paper)
024 7 $a 10.1007/978-3-319-13896-1 $2 doi
035 $a 978-3-319-13896-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RD546
072 7 $a MNK $2 bicssc
072 7 $a MED085000 $2 bisacsh
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 617.5562 $2 23
090 $a RD546 $b .E96 2017
245 0 0 $a Extreme hepatic surgery and other strategies $h [electronic resource] : $b increasing resectability in colorectal liver metastases / $c edited by Eduardo de Santibanes ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a xix, 383 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I Introduction. 1. Introduction -- 2. Liver surgical anatomy -- II. Global patient evaluation and oncological assessment -- 3. Resectability assessment with diagnostic imaging -- 4. Liver function evaluation before extreme liver surgery -- 5. Imaging-based preoperative planning -- 6. Choosing the best strategy. Multidisciplinary evaluation -- III -- Non-operative multimodal therapies -- 7. Conversion and neoadjuvant therapies -- 8. Portal embolization -- 9. Intraarterial chemotherapy -- 10. Radioembolization -- IV. Surgical strategies -- 11. Anesthetics management -- 12. Intraoperative evaluation of resectability -- 13. Vascular control in major hepatic resections -- 14. Two-stage liver surgery -- 15. Two-stage liver surgery with portal occlusion -- 16 ALPPS -- 17. Parenchymal-sparing liver resections -- 18. Combined vascular resections -- 19. Ex-vivo liver surgery -- 20. Liver transplant -- 21. The roll of laparoscopy in advanced liver disease -- V. Management of concomitant extrahepatic disease -- 22. Pulmonary metastases -- 23. Nodal involvement -- 24. Peritoneal disease -- 25. Adjacent organs invasion. Multivisceral resections -- VI. Postoperative complications and their management -- 26. Complications of hepatic resections -- VII. Palliative care -- 27. Palliative care in patients with extensive disease.
520 $a This book describes the diagnoses; staging and management of patients with colorectal liver metastases initially considered unresectable and portrays the different strategies to increase resectability along with their tactics and tricks. Colorectal carcinoma is the third most commonly diagnosed cancer in the world and according to recent cancer statistics around 1.23 million patients are diagnosed each year. Of these patients, approximately 50% will develop liver metastases during the course of their disease and around 15-25% are found to have stage IV disease at diagnosis. Liver resection has been recognized as the treatment of choice for these patients, offering overall 5-year survival rates of up to 50-60% and the only hope for cure. However, at diagnosis only 10-20% of these patients are possibly amenable to surgical resection with curative intent. The possibility to achieve an R0 resection is many times limited by the amount and quality of the future liver remnant (FLR), being posthepatectomy liver failure (PHLF) the most feared and severe complication after major liver resections. With the years, diverse strategies have been developed with the intention to increase resectability by increasing the future liver remnant and/or reducing tumor size, e.g. ALPPS. Along with these techniques, associated surgeries are developed including multivisceral resections, which broadens even more the resectability for patients.
650 0 $a Liver $x Surgery. $3 1244617
650 0 $a Liver $x Cancer $x Surgery. $3 1532474
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Surgical Oncology. $3 891112
650 2 4 $a Abdominal Surgery. $3 894452
650 2 4 $a Hepatology. $3 894467
650 2 4 $a Proctology. $3 850352
700 1 $a Santibanes, Eduardo de. $3 3250933
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-13896-1
950 $a Medicine (Springer-11650)